Close Menu

NEW YORK (GenomeWeb) — Centogene said today that it has entered a 12-month strategic collaboration with Sarepta Therapeutics for the identification of patients with Duchenne muscular dystrophy in the Middle East and North Africa.

Under the terms of the agreement with Sarepta, Centogene will provide diagnostic services to physicians treating patients exhibiting symptoms related to DMD.

Financial and other terms of the agreement were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

According to New Scientist, GEDmatch changed its terms and conditions over the weekend to opt its users out of law enforcement searches.

The Atlantic looks into time spent pursuing gene leads generated through candidate gene studies.

A twin study uncovers evidence that genes may influence whether someone gets a dog, Martha Stewart reports.

In PNAS this week: Cdx2 cells can help regenerate heart tissue in mice following a heart attack, PIWI-interacting small RNA levels in human cancer, and more.